|
American Oriental Bioengineering (AOBO) is firmly planted in the pharmaceutical industry. Through subsidiaries, AOBO makes more than 20 plant-based pharmaceuticals and nutraceuticals based on Traditional Chinese Medicine (TCM). Products include prescription and over-the-counter herbal and vitamin beverages, pills, gels, patches, and powders to treat a variety of ailments from bedwetting to respiratory diseases. It sells directly to some 100,000 retail stores, pharmacies, hospitals, and independent distributors who act as resellers. AOBO, which was founded in 1970, operates about 30 offices throughout China. CEO Tony Liu has a controlling ownership stake (about 40%) in the company.
|
| | | Contact Information | |
Address: |
No. 4018 Jintian Rd., Anlian Plaza, 12F Ste. B02, Futian Distric
Shenzhen, Heilongjiang 150086, China
| | Phone: | +86-451-8666-6601 | | Fax: | +86-451-8669-0967 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 264.60 M | | Revenue Growth (1 yr): | 64.90% | | Employees (2008): | 4,076 | | Employee Growth (1 yr): | 4.60% |
|
|
Key People
| | • |
Chairman and CEO:
Shujun (Tony) Liu
| | • |
COO, CFO, Secretary, and Director:
Yanchun (Lili) Li
| | • |
Head Marketing:
Zhang Mowen
|
|
|
